Trademarkia Logo

Australia

AU$
VYVANSE
Protected: Registered/protected

Last updated on 27 Feb 2025

Owner Info

Takada Pharmaceuticals U.S.A., Inc.

500 Kendall Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

1210244 filed on 28 Sept 2007

Correspondent

Troutman Pepper Locke LLP

c/o IP Services NYC,,

875 Third Avenue,

UNITED STATES OF AMERICA

VYVANSE

Classification Information


Class [005]
Pharmaceutical preparations acting on the central nervous system

Mark Details


Serial Number

1210244

Registered On

28 Sept 2007

Renewal On

28 Sept 2027

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

2 Apr 2007

Mark Type

US

Legal History


Show more

Status DateAction Taken
27th Feb 2025Amendment to International Registration Contact Requested
24th Jan 2025Owner name details updated
23rd Jan 2025International Registration - Correction Received
26th Dec 2024Amendment to Amend Owner Requested
21st Jun 2024Customer Amendment Made correspondence sent
21st Jun 2024Amendment to Address for Service Requested
9th Nov 2020Owner name details updated
9th Nov 2020Owner name details updated
9th Nov 2020Owner name details updated
9th Nov 2020Owner name details updated